NCT00168324 - A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion | Biotech Hunter

Enrollment

599

Participants

Timeline

Start Date

October 1, 2004

Primary Completion Date

March 1, 2008

Study Completion Date

October 1, 2008

Conditions

Macular EdemaRetinal Vein Occlusion

Interventions

DRUG

700 µg Dexamethasone

700 µg dexamethasone intravitreal implant administered on Day 0 and/or Day 180.

DRUG

350 µg Dexamethasone

350 µg Dexamethasone intravitreal implant administered on Day 0.

OTHER

Sham Injection

Sham injection on Day 0.

Trial Locations (13)

Los Angeles

Sydney

Graz

Halifax

Brno

Créteil

Karlsruhe

Rehovot

Tabacalera

Makati

Coimbra

Arcadia

Kaohsiung City